3 Biotech Stocks That Soared This Week: Are They Buys?
Earnings season continued to be in high gear this week. Positive quarterly results helped propel several biotech stocks higher over the last few days. Others jumped because of good news for their pipelines.
Three biotech stocks that especially soared this week were Nektar Therapeutics (NASDAQ: NKTR), Sage Therapeutics (NASDAQ: SAGE), and Valeant Pharmaceuticals (NYSE: VRX). Here's what lit a fire under these stocks -- and, more importantly, whether they're smart picks for investors after the huge gains.
Image source: Getty Images.
Source: Fool.com
Sage Therapeutics Inc. Stock
€10.01
0.860%
Our community is currently high on Sage Therapeutics Inc. with 8 Buy predictions and 4 Sell predictions.
Based on the current price of 10.01 € the target price of 26 € shows a potential of 159.87% for Sage Therapeutics Inc. which would more than double the current price.
